Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127500762 | 12750076 | 2 | F | 20160903 | 20160922 | 20160916 | 20160929 | EXP | CA-JNJFOC-20160907070 | JANSSEN | 55.31 | YR | A | M | Y | 0.00000 | 20160929 | CN | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127500762 | 12750076 | 1 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | N | 0 | 45 | MG | SOLUTION FOR INJECTION | ||||||
127500762 | 12750076 | 2 | PS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | N | 125261 | 45 | MG | SOLUTION FOR INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127500762 | 12750076 | 1 | Psoriasis |
127500762 | 12750076 | 2 | Psoriasis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127500762 | 12750076 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127500762 | 12750076 | Lower respiratory tract infection | |
127500762 | 12750076 | Malaise | |
127500762 | 12750076 | Nasopharyngitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127500762 | 12750076 | 1 | 20131106 | 0 | ||
127500762 | 12750076 | 2 | 20111128 | 0 |